{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T06:28:59Z","timestamp":1775284139210,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL131017"],"award-info":[{"award-number":["R01HL131017"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008522","name":"University of Illinois at Chicago","doi-asserted-by":"publisher","award":["58796"],"award-info":[{"award-number":["58796"]}],"id":[{"id":"10.13039\/100008522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008522","name":"University of Illinois at Chicago","doi-asserted-by":"publisher","award":["SCR_020997"],"award-info":[{"award-number":["SCR_020997"]}],"id":[{"id":"10.13039\/100008522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CHO-K1"],"award-info":[{"award-number":["CHO-K1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["F31CA236190"],"award-info":[{"award-number":["F31CA236190"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM136309"],"award-info":[{"award-number":["R35GM136309"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jconrel.2025.02.033","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T03:49:17Z","timestamp":1740196157000},"page":"967-975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Syncytial therapeutics: Receptor-specific and direct-to-cytosol biologic drug delivery mediated by measles fusion complex"],"prefix":"10.1016","volume":"380","author":[{"given":"Victor A.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casim A.","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda M.","family":"Ogle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.02.033_bb0005","first-page":"131","article-title":"Living cell for drug delivery","volume":"3","author":"Wu","year":"2022","journal-title":"Eng. Regener."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10529-023-03461-0","article-title":"Recent advances and current challenges in CAR-T cell therapy","volume":"46","author":"Joy","year":"2024","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","article-title":"Engineering the next generation of cell-based therapeutics","volume":"21","author":"Bashor","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01723-z","article-title":"CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances","volume":"22","author":"Maalej","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0025","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1007\/s12274-018-2179-5","article-title":"Cell-based drug delivery systems for biomedical applications","volume":"11","author":"Li","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/d41573-023-00140-7","article-title":"The next-generation CAR-T therapy landscape","volume":"22","author":"Verma","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1236345","article-title":"Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements","volume":"10","author":"Huerta","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13287-022-03054-0","article-title":"Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review","volume":"13","author":"Margiana","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13346-022-01211-9","article-title":"Nanotechnology-based cell-mediated delivery systems for cancer therapy and diagnosis","volume":"13","author":"Alimardani","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40164-023-00373-7","article-title":"Current advances and challenges in CAR T-cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment","volume":"12","author":"Yan","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","article-title":"Exosome engineering in cell therapy and drug delivery","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s41232-023-00287-1","article-title":"Stem cell-based drug delivery strategy for skin regeneration and wound healing: potential clinical applications","volume":"43","author":"Zhang","year":"2023","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12951-023-02259-6","article-title":"Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review","volume":"22","author":"Chen","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/d41573-020-00220-y","article-title":"Exosome-based candidates move into the clinic","volume":"20","author":"Cully","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s13346-022-01225-3","article-title":"The exosome: a review of current therapeutic roles and capabilities in human reproduction","volume":"13","author":"Dimik","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12951-024-02634-x","article-title":"Exosome for mRNA delivery: strategies and therapeutic applications","volume":"22","author":"Iqbal","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"D\u00f6rig","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0090","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"Tatsuo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10409230802058320","article-title":"Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme","volume":"43","author":"White","year":"2008","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nsmb.2432","article-title":"Structure of measles virus hemagglutinin bound to its epithelial receptor nectin-4","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2014.01.005","article-title":"Activation of paramyxovirus membrane fusion and virus entry","volume":"5","author":"Jardetzky","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2014.10.001","article-title":"Unity in diversity: shared mechanism of entry among paramyxoviruses","volume":"129","author":"Palgen","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s40588-016-0040-8","article-title":"Paramyxovirus glycoproteins and the membrane fusion process","volume":"3","author":"Aguilar","year":"2016","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/v8090250","article-title":"The host cell receptors for measles virus and their interaction with the viral hemagglutinin (H) protein","volume":"8","author":"Lin","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1166\/jnn.2014.9082","article-title":"Endosomal escape: a bottleneck in intracellular delivery","volume":"14","author":"Shete","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0130","article-title":"Lipid nanoparticles optimized for targeting and release of nucleic acid","volume":"36","author":"Jia","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110804","article-title":"pH-responsive cationic liposome for endosomal escape mediated drug delivery","volume":"188","author":"Rayamajhi","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0140","doi-asserted-by":"crossref","first-page":"P69","DOI":"10.1186\/1753-6561-9-S9-P69","article-title":"Intracellular trafficking pathways for plasmid DNA complexed with highly efficient endosome escape polymers","volume":"9","author":"Gillard","year":"2015","journal-title":"BMC Proc."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0145","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1021\/bc800530v","article-title":"Cytosolic targeting of macromolecules using a pH-dependent fusogenic peptide in combination with cationic liposomes","volume":"20","author":"Kobayashi","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0150","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1073\/pnas.81.6.1715","article-title":"pH-sensitive liposomes: acid-induced liposome fusion","volume":"81","author":"Connor","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2007.04.035","article-title":"Cationic liposome (DC-Chol\/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression","volume":"342","author":"Maitani","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0160","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2174\/0929867033457430","article-title":"Cationic liposomes for gene delivery: from biophysics to biological applications","volume":"10","author":"Pedroso de Lima","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201902952","article-title":"Securing the payload, finding the cell, and avoiding the endosome: peptide-targeted, Fusogenic porous silicon nanoparticles for delivery of siRNA","volume":"31","author":"Kim","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/srep10112","article-title":"Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes","volume":"5","author":"Nakase","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21101284","article-title":"Improvement of peptide-based tumor immunotherapy using pH-sensitive Fusogenic polymer-modified liposomes","volume":"21","author":"Yoshizaki","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0185","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.biomaterials.2009.10.006","article-title":"pH-sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity","volume":"31","author":"Yuba","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0190","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1242\/jcs.066399","article-title":"Breaking down the barriers: siRNA delivery and endosome escape","volume":"123","author":"Dominska","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0195","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0200","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.mt.6300105","article-title":"Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas","volume":"15","author":"Paraskevakou","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0205","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1182\/blood-2002-07-2195","article-title":"Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker","volume":"101","author":"Peng","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nbt942","article-title":"Antibody-targeted cell fusion","volume":"22","author":"Nakamura","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nbt1060","article-title":"Rescue and propagation of fully retargeted oncolytic measles viruses","volume":"23","author":"Nakamura","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0220","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1158\/0008-5472.CAN-06-1200","article-title":"Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity","volume":"66","author":"Allen","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-3-031-37936-9_14","article-title":"Virus-induced cell fusion and syncytia formation","volume":"71","author":"Xie","year":"2024","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0230","series-title":"Syncytia: Origin, Structure, and Functions","first-page":"433","article-title":"Cell fusion and syncytia formation in cancer","author":"Sieler","year":"2024"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0235","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1096\/fj.15-271098","article-title":"Apoptosis-induced cancer cell fusion: a mechanism of breast cancer metastasis","volume":"29","author":"Noubissi","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0240","doi-asserted-by":"crossref","DOI":"10.1063\/1.5024744","article-title":"Breast tumor cell hybrids form spontaneously in vivo and contribute to breast tumor metastases","volume":"2","author":"Chitwood","year":"2018","journal-title":"APL Bioeng"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0245","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1158\/0008-5472.CAN-03-3753","article-title":"Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer","volume":"64","author":"Ebert","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0250","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0255","first-page":"1634","article-title":"Cellpose 2.0: how to train your own model. Nat","volume":"19","author":"Pachitariu","year":"2022","journal-title":"Methods"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41592-025-02595-5","article-title":"Cellpose3: one-click image restoration for improved cellular segmentation","author":"Stringer","year":"2025","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0265","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.84.2189.533.a","article-title":"The use of the terms coenocyte and syncytium in biology","volume":"84","author":"Daubenmire","year":"1936","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0270","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1073\/pnas.1105351108","article-title":"Designing super selectivity in multivalent nano-particle binding","volume":"108","author":"Martinez-Veracoechea","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0275","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1021\/jacs.8b12553","article-title":"Multivalent recognition at fluid surfaces: the interplay of receptor clustering and Superselectivity","volume":"141","author":"Dubacheva","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/9781119143505.ch3","article-title":"Design principles for super selectivity using multivalent interactions","author":"Curk","year":"2018","journal-title":"Multivalency: Concepts, Research & Applications"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0285","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/mt.2013.16","article-title":"DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety","volume":"21","author":"Friedrich","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0290","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fimmu.2018.00492","article-title":"Simian immunodeficiency virus (SIV)-specific chimeric antigen receptor-T cells engineered to target B cell follicles and suppress SIV replication","volume":"9","author":"Haran","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-0716-1944-5_12","article-title":"Production and characterization of SIV-specific CAR\/CXCR5 T cells","volume":"2421","author":"Pampusch","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0300","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4049\/immunohorizons.2200073","article-title":"HIV-specific CAR T cells with CD28 or 4-1BB signaling domains are phenotypically and functionally distinct and effective at suppressing HIV and simian immunodeficiency virus","volume":"6","author":"Cartwright","year":"2022","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.jconrel.2025.02.033_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009831","article-title":"CAR\/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection","volume":"18","author":"Pampusch","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0310","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1128\/JVI.00078-07","article-title":"Cell-cell fusion induced by measles virus amplifies the type I interferon response","volume":"81","author":"Herschke","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.02.033_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300319","article-title":"A comparison of cellular uptake mechanisms, delivery efficacy, and intracellular fate between liposomes and extracellular vesicles","volume":"12","author":"Gandek","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.02.033_bb0320","first-page":"169","article-title":"Liposomes as drug delivery systems: properties and applications","volume":"4","author":"Moghimipour","year":"2013","journal-title":"Res. J. Pharm., Biol. Chem. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:55:07Z","timestamp":1770141307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925001464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":64,"alternative-id":["S0168365925001464"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.033","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syncytial therapeutics: Receptor-specific and direct-to-cytosol biologic drug delivery mediated by measles fusion complex","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}